Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in PCSK9 Inhibitors
by Highest Patent Value in the world in 2019

The PCSK9 Inhibitors top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value PCSK9 Inhibitors Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
The PCSK9 inhibitors are a class of injectable drugs approved in 2015 that have been shown to dramatically lower LDL cholesterol levels -- by up to 60% in some cases -- when combined with a statin.. PCSK9 inhibitors are monoclonal antibodies (MABs), a type of biologic drug. They bind to and inactivate an enzyme in the liver called proprotein convertase subtilisin kexin 9 (PCSK9).
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 1.94 M
2
Ontario, Canada
Avg patent value: 1.19 M
3
Avg patent value: 1.19 M
4
United Kingdom
Avg patent value: 621,950
5
Avg patent value: 290,000
6
Switzerland
Medicine,Health care,Drug,
...[+2]
Avg patent value: 290,000
7
Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER,
...[+2]
Avg patent value: 91,218
8
Guangdong Sheng, China
Avg patent value: 79,000
9
IF, FR
Avg patent value: 53,500
10
Cambridgeshire, United Kingdom
Medicine,Health care,Side effect,
...[+2]
Avg patent value: 47,625
11
Cambridgeshire, United Kingdom
Avg patent value: 47,625
12
Dogma Therapeutics, Inc.
PCSK9,Cardiovascular agent,Biophysics,
...[+2]
Avg patent value: 45,500
13
Avg patent value: 38,200
14
Basel-Stadt, Switzerland
Dosage form,Health care,Medicine,
...[+2]
Avg patent value: 37,536
15
Hovedstaden, Denmark
Insulin,Health care,Haemophilia,
...[+2]
Avg patent value: 32,787
16
South Korea
Avg patent value: 3,700
17
Pokka Corp.
Aichi, Japan
Food industry,Soft drink,Fountain,
...[+1]
Avg patent value: 3,600
18
Health care,Biopharmaceutical,Drug,
...[+2]
Avg patent value: 0
19
Île-de-France, France
Health care,Pharmacy and Therapeutics,Drug,
...[+2]
Avg patent value: 0
20
Avg patent value: 0
Page generation time: May 17 2025